arrow
P

Philippe Lyrer

university of basel
H指数:67
被引数:1.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Increased risk of recurrent stroke in patients with impaired kidney function: results of a pooled analysis of individual patient data from the MICON international collaboration
2025-04-010
PRE
The 6-months follow-up of the TREAT-CAD trial: Aspirin versus anticoagulation for stroke prevention in patients with cervical artery dissection

TREAT-CAD试验的6个月随访:在颈动脉夹层患者中,阿司匹林与抗凝治疗用于卒中预防的比较

2025-02-050
PRE
Enhancement of STroke REhabilitation with Levodopa (ESTREL): Rationale and design of a randomized placebo-controlled, double blind superiority trial

左旋多巴 (ESTREL) 增强中风康复: 随机安慰剂对照,双盲优势试验的原理和设计

2024-06-090
OA
Andexanet alfa versus non-specific treatments for intracerebral hemorrhage in patients taking factor Xa inhibitors - Individual patient data analysis of ANNEXA-4 and TICH-NOAC
2024-03-0810
PRE
Toward Individual Treatment in Cervical Artery Dissection: Subgroup Analysis of the TREAT-CAD Randomized Trial

颈动脉夹层的个体化治疗: TREAT-CAD随机试验的亚组分析

2024-02-165
OA
Biomarker, Imaging, and Clinical Factors Associated With Overt and Covert Stroke in Patients With Atrial Fibrillation

与心房颤动患者的明显和隐蔽卒中相关的生物标志物,影像学和临床因素

STROKE
IF8.9
2023-10-013
OAAI
Tranexamic Acid for Intracerebral Hemorrhage in Patients on Non-Vitamin K Antagonist Oral Anticoagulants (TICH-NOAC): A Multicenter, Randomized, Placebo-Controlled, Phase 2 Trial

氨甲环酸治疗非维生素k拮抗剂口服抗凝剂 (tich-noac) 患者的脑出血: 一项多中心,随机,安慰剂对照的2期试验

STROKE
IF8.9
2023-09-0113
OAAI
The impact of competing stroke etiologies in patients with atrial fibrillation
2023-07-044
OAAI
Intravenous Thrombolysis 4.5-9 Hours After Stroke Onset: A Cohort Study from the TRISP Collaboration
2023-05-131
OA
Impact of Cerebral Microbleeds in Stroke Patients with Atrial Fibrillation
2023-04-1711
OA
Atrial Fibrillation Detected before or after Stroke: Role of Anticoagulation
2023-04-1319
OA
Stroke Risk and Antithrombotic Treatment During Follow-up of Patients With Ischemic Stroke and Cortical Superficial Siderosis
2023-03-212
OA
Mechanical Thrombectomy Versus Best Medical Treatment in the Late Time Window in Non-DEFUSE-Non-DAWN Patients: A Multicenter Cohort Study

在非DEFUSE-非DAWN患者的晚期时间窗中,机械血栓切除术与最佳药物治疗的比较: 一项多中心队列研究

STROKE
IF8.9
2023-03-0112
OAAI
Apical pulmonary lesions suspected of malignancy visible on neck CT angiography performed for acute stroke: Prevalence, treatment, and clinical implications - the PLEURA study

急性卒中颈部CT血管造影显示的疑似恶性肺根尖病变: 患病率、治疗和临床意义-胸膜研究

2023-01-234
OA
Mechanical thrombectomy for large vessel occlusion between 6 and 24 h: outcome comparison of DEFUSE-3/DAWN eligible versus non-eligible patients

6至24 h之间大血管闭塞的机械血栓切除术: DEFUSE-3/DAWN合格患者与不合格患者的结果比较

2022-12-145
PRE
Intravenous Thrombolysis in Patients With Ischemic Stroke Aged ≥90 Years: A Cohort Study From the TRISP Collaboration
STROKE
IF8.9
2022-12-014
OA
Recurrent Ischemic Stroke and Bleeding in Patients With Atrial Fibrillation Who Suffered an Acute Stroke While on Treatment With Nonvitamin K Antagonist Oral Anticoagulants: The RENO-EXTEND Study

接受非维生素k拮抗剂口服抗凝剂治疗的房颤患者复发性缺血性卒中和出血: reno-extend研究

STROKE
IF8.9
2022-08-0143
OA